The efficacy of reminiscence therapy on the cognition of older patients with cognitive impairment or dementia: a meta-analysis based on regulatory factors
Open Access
- 9 January 2026
- journal article
- review article
- Published by Springer Nature in Aging Clinical and Experimental Research
- Vol. 38 (1)
Abstract
Background With global aging, dementia prevalence is rising, imposing significant burdens. Reminiscence therapy (RT) shows promise for improving cognition in older adults with cognitive impairment or dementia, but evidence remains inconsistent, potentially moderated by factors like age, intervention frequency, and setting. Aims This systematic review and network meta-analysis aimed to evaluate RT’s efficacy on cognitive function in older patients with cognitive impairment or dementia and identify moderating factors through subgroup analyses. Methods A comprehensive search was conducted across 11 English and Chinese databases from inception until May 1, 2025, to identify eligible randomized controlled trials (RCTs) evaluating RT versus standard care in older adults with cognitive impairment or dementia, utilizing the cognitive outcome. Two independent reviewers screened the studies, extracted data, and assessed risk of bias and evidence quality. Using RevMan 5.4 for meta-analysis and subgroup analysis. Results Twenty-four RCTs involving 1,963 patients were included. RT significantly improved cognitive function, with benefits sustained at follow-up. RT also improved memory, reduced depression, and enhanced quality of life, but not executive function. Subgroup analyses revealed significantly greater cognitive improvement in patients aged 60–70 years, with intervention frequencies of 12–16 sessions, and in nursing home settings. Conclusion RT is an effective intervention for improving cognition, memory, depression, and quality of life in older adults with cognitive impairment or dementia. Patient age, intervention frequency, and setting are potential moderators of its cognitive efficacy, providing actionable insights for optimizing clinical RT protocols.Keywords
Funding Information
- Shanghai Baoshan Science and Technology Commission (2024-E-66)
This publication has 79 references indexed in Scilit:
- The role of the left medial prefrontal cortex and posterior cingulate cortex in processing positive emotional words: evidence from a meta-analysis and an empirical studyBrain Structure and Function, 2025
- Efficacy of reminiscence therapy in improving cognitive decline: a systematic review and meta-analysisNeurological Sciences, 2024
- Multicentre randomised controlled trial about the effect of individual reminiscence therapy in older adults with neurocognitive disordersInternational Journal of Geriatric Psychiatry, 2020
- Assessment of Reported Comparative Effectiveness and Safety of Atypical Antipsychotics in the Treatment of Behavioral and Psychological Symptoms of DementiaJAMA Network Open, 2019
- The effect of reminiscence therapy on cognitive functions, depression, and quality of life in Alzheimer patients: Randomized controlled trialInternational Journal of Geriatric Psychiatry, 2018
- Reminiscence therapy for dementiaCochrane Database of Systematic Reviews, 2018
- Do antipsychotics lead to cognitive impairment in dementia? A meta-analysis of randomised placebo-controlled trialsEuropean Archives of Psychiatry and Clinical Neuroscience, 2016
- The prevalence of mild cognitive impairment about elderly population in China: a meta-analysisInternational Journal of Geriatric Psychiatry, 2010
- Group reminiscence therapy for cognitive and affective function of demented elderly in TaiwanInternational Journal of Geriatric Psychiatry, 2007
- Mild Cognitive ImpairmentArchives of Neurology, 1999